Loading people...
Ross Youngs is a Principal at the seed-stage venture fund BEEVC, based in San Francisco, California. Before joining BEEVC, he served as an investor at Andreessen Horowitz within the a16z Talent x Opportunity initiative, where he sourced deals and supported early-stage founders after earning a Bachelor of Arts in Economics from Stanford University. In his current capacity at the firm, Youngs has backed more than 20 startups, including a notable early investment in the artificial intelligence platform Character.ai. He frequently participates in the broader technology ecosystem, speaking at major industry events such as TechCrunch Disrupt and San Francisco Tech Week, while publishing a dedicated newsletter focused on developer tools. Youngs currently centers his investment strategy on pre-seed and seed-stage technology companies operating across the artificial intelligence infrastructure, financial technology, and future of work sectors.
Ross Youngs is CEO & Founder at Biosortia Pharmaceuticals.